These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28458232)

  • 1. Cortisol: Mediator of association between Alzheimer's disease and diabetes mellitus?
    Notarianni E
    Psychoneuroendocrinology; 2017 Jul; 81():129-137. PubMed ID: 28458232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer's disease initiation and development.
    Notarianni E
    Curr Alzheimer Res; 2013 Sep; 10(7):714-31. PubMed ID: 23906001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.
    Akomolafe A; Beiser A; Meigs JB; Au R; Green RC; Farrer LA; Wolf PA; Seshadri S
    Arch Neurol; 2006 Nov; 63(11):1551-5. PubMed ID: 17101823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
    In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.
    Martins IJ; Hone E; Foster JK; Sünram-Lea SI; Gnjec A; Fuller SJ; Nolan D; Gandy SE; Martins RN
    Mol Psychiatry; 2006 Aug; 11(8):721-36. PubMed ID: 16786033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing's syndrome: a large population database study.
    Dery L; Stern J; Shimon I; Rudman Y; Kushnir S; Shochat T; Fleseriu M; Akirov A
    Pituitary; 2024 Aug; 27(4):389-402. PubMed ID: 38769229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.
    Goldwaser EL; Acharya NK; Sarkar A; Godsey G; Nagele RG
    J Alzheimers Dis; 2016 Sep; 54(2):445-56. PubMed ID: 27497477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid levels of hypothalamic-pituitary-adrenal axis hormones in MCI and dementia due to Alzheimer's disease: a systematic review.
    Duarte-Zambrano F; Barrero JA; Mockus I
    Dement Neuropsychol; 2023; 17():e20230031. PubMed ID: 38089172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult Cushing's syndrome in type-2 diabetes.
    Catargi B; Rigalleau V; Poussin A; Ronci-Chaix N; Bex V; Vergnot V; Gin H; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5808-13. PubMed ID: 14671173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of hypercortisolism in depression.
    Carroll BJ; Cassidy F; Naftolowitz D; Tatham NE; Wilson WH; Iranmanesh A; Liu PY; Veldhuis JD
    Acta Psychiatr Scand Suppl; 2007; (433):90-103. PubMed ID: 17280575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease.
    Rasmuson S; Näsman B; Olsson T
    Int Psychogeriatr; 2011 Nov; 23(9):1386-92. PubMed ID: 21729423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.